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Rapid Isolation of Mononuclear Cells from 
Buffy Coats Prepared by a New Blood Cell 
Separator 1
Carl G. Figdor 2, Willy S. Bont and Jan E. De Vries
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Amsterdam, The Netherlands
(Received 1 February 1982, accepted 10 May 1982)
A newly developed cell separator for the preparation and fractionation of buffy coat cells from human 
peripheral blood is described. In this cell separator buffy coats (BC-1) as routinely obtained from blood 
banks were used for the preparation of a second buffy coat (BC-2) with a volume of only 5-6  ml. A 
special fractionation device allowed sterile isolation of almost pure platelets and mononuclear cells with 
recoveries of 75 ±10% and 89 + 4% respectively. The white blood cell contamination of the platelet 
suspension never exceeded 20X106 leukocytes (i.e., <1 leukocyte per 5000 platelets). Furthermore, the 
mononuclear cell suspensions were shown to be contaminated with only 3 ±2% granulocytes, whereas the 
white blood cell/red blood cell ratio was 2.6 ±  1.6, so that they could therefore be directly used for further 
separation by means of centrifugal élutriation.
These results indicate that this cell separator provides a rapid ( ±  1 h) isolation of both platelets and 
mononuclear cells without exposing the buffy coat cells to foreign substances like Ficoll or Percoll.
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Introduction
Centrifugation over density gradients of Ficoll-Hypaque (Boyum, 1968) or more 
recently Percoll (Pertoft et al.? 1979) is a widely used procedure to isolate mono­
nuclear cells from human peripheral blood. However, if large numbers of m ono­
nuclear cells are required and therefore larger volumes of blood have to be 
processed, these techniques become rather laborious and time-consuming, even if the 
number of red blood cells of 1 unit blood (500 ml) is reduced by the preparation of a 
buffy coat.
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We previously reported that the red blood cell contamination of a buffy coat 
could be reduced by a factor 2 by the preparation of a second buffy coat (BC-2) 
(Figdor et al., 1981). The aim of the present study was to investigate whether this red 
blood cell contamination could be further reduced.
We report here that the preparation of a second buffy coat in a specially devised 
cell separator resulted in a marked reduction of red blood cell contamination. In 
addition we demonstrate that the buffy coat formed in this cell separator is 
com posed of 2 layers which could be fractionated separately: the top layer contain­
ing almost pure platelets, the second layer containing almost pure mononuclear cells 
contaminated with low numbers of red blood cells.
Materials and Methods
D escrip tion  o f  the blood cell separator
The cell separator as shown in Fig. 1 (manufactured by D e Koningh, Arnhem,
Fig. 1. The blood cell separator.
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Fig. 2. The cell separator and the fractionation device in cross section. A: the cell separator consists of a 
lower compartment with an inlet (i,) covered with a self'Sealing rubber septum (s) and is connected with 
the upper compartment by a narrow tube (t). B: the fractionation device can be placed on the top of the 
apparatus and consists of an inlet tube (i2) and an outlet tube (o). The lower part of the outlet tube is 
centered into the connection tube by an o-ring (or) in such a way that fluid still can pass.
The Netherlands) is made of glass and has a diameter o f approximately 8 cm, and a
i
height of 18 cm. It can be placed into a bucket of a refrigerated centrifuge with an 
inner diameter of 8.2 cm and a height of 17.5 cm (MSE-Mayor, MSE, Sussex). The 
separator consists of 2 compartments connected by a narrow tube (t) with an inner 
diameter of 5 mm (Fig. 2A). The lower compartment, which has a volume of 
approximately 150 ml, has an inlet (ix) that permits the injection of fluid. The upper 
compartment has a volume of approximately 180 ml. The cell separator can be filled 
via an opening at the top of the upper compartment, and fractionation is achieved 
by means of a special device (Fig. 2B).
Principles of the isolation of human peripheral blood cells
After centrifugation of human peripheral blood 3 components can be dis­
tinguished: plasma at the top, red blood cells at the bottom and the buffy coat 
(containing platelets and leukocytes) in a very thin layer at the interface. This buffy  
coat is generally too thin to be harvested without considerable contamination with 
plasma and red blood cells. Since the thickness of the buffy coat is inversely related 
to its surface area, we reasoned that better fractionation would be obtained if the 
thickness of the buffy coat could be increased by reducing its surface area. 
Therefore, the isolation of white blood cells would be optimal if the buffy coat could
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be formed in the connecting tube of the cell separator during centrifugation. 
However, pilot studies showed that, due to the small volume of the connection tube 
( <  0.5 ml), slight variations in hematocrit resulted in formation of the buffy coat 
either above or below the connecting tube. It was found, however, that optimal 
separation was obtained if the buffy coat were formed just below the connecting 
tube and was subsequently transported into the connection tube by addition of 
Maxidens, a non-toxic autoclavable fluid, immiscible with blood, which has a 
density of 1.9 g /m l (Nyegaard, Oslo) (see for details below).
Operation
Buffy coats (BC-1) routinely prepared by centrifugation (20 min, 1000 X g)  of 1 
unit of human peripheral blood, were collected in 60-100 ml (BC-1 were obtained 
from the Central Laboratory of the Netherlands Red Cross Blood Transfusion 
Service, Amsterdam). After determination of the hematocrit the volume of Maxidens 
(md) required was calculated by the formula
md =  140 — X V
A
BC-1
md
B C
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n
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Fig. 3. Schematic representation of the separation and fractionation procedure. A: before centrifugation. 
The cell separator was filled with BC-1 and Maxidens (md) to adjust the volume of the lower 
compartment. To keep the rotor of the centrifuge in balance a second separator was filled with an equal 
volume of Maxidens and a sucrose solution instead of blood. B: after centrifugation. BC-2 has formed just 
below the connecting tube, rbc — red blood cells, Pa — plasma. C: BC-2, which consists of 2 layers, 
platelets (PI) and leukocytes (leuc), fractionated by a special device as shown and simultaneous injection 
of Maxidens and 0.9% NaCl (see Materials and Methods). Cells were collected into tubes filled with 2.5 
ml PBS (containing 1.4% bovine serum albumin and 10 U heparin/ml to facilitate accurate cell counting).
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in which H =  hematocrit, V = volume of BC-1 and 140 is the volume of the lower 
compartment that allowed BC-2 formation just below the connection tube. The cell 
separator was filled with Maxidens and BC-1, diluted 1:1  with phosphate-buffered 
saline (PBS) containing 15% acidic citrate dextrose (ACD) via the opening at the top 
(Fig. 3A). After centrifugation for 30 min, 500 X g9 at room temperature, BC-2 
formed just below the connecting tube (Fig. 3B). The BC-2 cells were collected after 
placing a fractionation device in the cell separator and connecting i 2 (Fig. 2) with a 
plastic bag containing 0.9% NaCl (Fig, 3C). The surface area of BC-2 was reduced 
by moving the BC-2 cells into the connecting tube by injection of Maxidens via i j 
(Fig. 2) with a flow rate of 1.6 m l/m in  generated by hydrostatic pressure. When the 
BC-2 cells arrived in the connecting tube, the flow rate of Maxidens was reduced to 
0.3 m l/m in  and at the same time the 0.9% NaCl solution was introduced at a flow 
rate of 0.5 m l/m in . In this way BC-2 cells and plasma were simultaneously 
transported through the outlet tube, and the different cell fractions were collected 
without disturbance of the various cell layers in BC-2. This procedure has the 
advantage that the plasma acts as a sheath flow stream for the BC-2 cells and thus 
prevents sticking of these cells to the inner side of the outlet tube.
In all, 7 fractions were collected visually. The white top layer of the BC-2 was 
collected in fraction 1. The pink middle layer was collected arbitrarily in 5 different 
fractions, and the remaining red blood cell layer was collected in fraction 7.
Results
The results of isolation and fractionation of BC-2 cells after dilution o f BC-1 cells 
are shown in Tables I and II. On average, 103 ±  6% of the leukocytes present in 
BC-1 were recovered in the 7 fractions. 75 ±  10% of the thrombocytes were re­
covered in fraction 1 in a volume of 2.6 ±  0.7 ml. This thrombocyte fraction was 
almost pure, the white blood cell contamination being always less than 20 X 106 cells 
(i.e., < 1 white blood cell per 5000 thrombocytes), 89 +  4% of the mononuclear cells 
were recovered in fractions 2 -5  in a total volume of 2.7 ±  0.7 ml. The average 
contamination with granulocytes of these mononuclear cell fractions was only 
3 ±  2%. Fraction 6 contained relatively few white blood cells, including both  
mononuclear cells and granulocytes. Fraction 7 contained the packed red blood cells 
and most of the granulocytes present in BC-1.
Separation was shown to be less efficient if BC-1 was not diluted, when the 
concentration of granulocytes in the fractions 2 -5  doubled and the recovery of 
mononuclear cells was slightly decreased (Table III).
Discussion
Red blood cells were efficiently removed from BC-1, as routinely prepared by 
blood banks, by the preparation of a second buffy coat (BC-2) in a specially 
designed cell separator. Careful fractionation of the BC-2 preparation resulted in
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TABLE I
COM POSITION OF TH E FRACTIONS OBTAINED FROM BC-2
BC-1 cells were diluted 1:1 with PBS/ACD, centrifuged at 1500 rev/m in for 30 min, and fractionated 
into 7 fractions. The fractions were differentiated after staining for MGG and non-specific esterase, The
Experiment 1 Experiment 2
W B C a Percentage WBC Percentage
XlO6 XlO6 -------------------------
Ly Mo Gr Ly Mo Gr
BC-1 1720 30 12 58 1980 35 16 49
Fraction 1 <1 100 0 0 17 100 — —
2 86 77 20 3 31 96 3 1
3 225 69 30 1 76 87 12 1
4 384 72 25 3 397 60 39 1
5 109 68 27 5 312 79 20 1
6 42 49 39 12 80 43 20 37
7 1060 8 2 90 1 105 1 2 97
% Recovery 111 102
a WBC = white blood cells.
TABLE II
YIELD A N D  CONTAMINATION OF THE MONONUCLEAR CELL SUSPENSIONS FROM BC-2 
OBTAINED FROM BC^l DILUTED 1:1
BC-2 was prepared from diluted BC-1 (1:1), After centrifugation the fractions 2, 3, 4 and 5 containing 
predominantly mononuclear cells were recombined. Granulocyte contamination and white blood cell/red 
blood cell ratio was determined by cytospin centrifuge preparations after M GG staining.
Experiment
no.
White blood cells 
x lO 6
% Granulocytes % Recovered 
mononuclear cells
White blood ce ll/ 
red blood cell ratio
1 805 3 82 3.0
2 816 1 89 1.3
3 635 5 93 2.8
4 443 2 88 1.8
5 670 6 95 0.3
6 593 2 84 4.1
7 473 6 90 0.7
8 608 2 91 4.9
M ean±S .D . 3 ± 2 89 + 4 2.4+1.6
almost pure thrombocytes and mononuclear cell suspensions, with recoveries of 
70—90% and 89% respectively. The rather large variation in number of white blood 
cells present in the buffy coats did not affect the separation. Optimal cell separation
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rather large variation in the number of white blood cells that contaminated the platelets in fraction 1 was 
due to the fact that cuts between the various fractions were made visually.
Experiment 3 Experiment 4 Experiment 5
WBC
XlO6
Percentage WBC
x lO 6
Percentage WBC
X106
Percentage
Ly Mo Gr Ly Mo Gr Ly Mo G r
1773 27 11 62 972 49 16 35 1081 41 Î7 42
19 69 25 6 10 89 Î1 — 14 56 41 2
16 76 19 5 74 73 27 — 84 69 28 3
206 56 38 6 110 79 20 1 184 69 25 6
210 62 30 8 144 70 28 2 183 72 24 4
203 68 27 5 115 75 22 3 257 76 15 9
70 9 2 89 31 66 21 13 23 11 6 83
1133 — 2 98 420 4 4 92 372 5 1 94
105 93 103
TABLE III
YIELD AND GRANULOCYTE CONTAMINATION OF THE MONONUCLEAR CELL SUSPEN­
SIONS FROM BC-2 OBTAINED FROM UNDILUTED BC-1
BC-2 were prepared from BC-1 that were not diluted. After centrifugation the fractions 2, 3, 4 and 5 
containing predominantly mononuclear cells were recombined. The % granulocytes was determined by 
cytospin centrifuge preparations after MGG staining.
Experiment
no.
White blood cells 
*X106
% Granulocytes % Recovered 
mononuclear cells
1 730 5 97
2 400 2 83
3 569 11 81
4 495 6 73
5 650 6 89
6 525 7 90
M ean±S.D. 6 ± 3 86 ± 8
was obtained if the BC-1 were diluted before centrifugation, which may be explained 
by the reduction of both the density and the viscosity of the plasma. In addition, 
centrifugation at room temperature resulted in better separation than centrifugation 
at a lower temperature (10°C), which accords with observations of Freireich et al. 
(1965).
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The cell separator was also used for preparation of buffy coats from 300 ml of 
whole blood. In a single centrifugation step pure thrombocyte and mononuclear cell 
preparations were obtained as described above (data not shown). A smaller version 
of the cell separator, constructed to process small volumes (50 ml) of whole blood, 
also allowed efficient separation of thrombocytes and mononuclear cells, although 
red blood cell contamination was slightly higher. These findings show that the 
technique allows isolation of mononuclear cells with low red blood cell contamina­
tions from buffy coats as well as whole blood.
Furthermore, we have shown that mononuclear cells (derived from one unit of 
blood) isolated by this technique could be used directly for efficient separation of 
m onocytes and lymphocytes by centrifugal élutriation (Figdor et al., 1982) whereas 
whole blood and buffy coats as routinely prepared by blood banks, result in 
overloading of the separation chamber of the elutriator rotor (Van Es and Bont, 
1980). Isolation of lymphocytes and monocytes in this way has the advantage that 
contact between the buffy coat and body foreign substances like Percoll and 
Ficoll-Hypaque is avoided.
Although other techniques such as intermittent flow centrifugation (Aisner et a l, 
1976) and continuous flow centrifugation (Freireich et al., 1965; Judson et al., 1968; 
Hester et al., 1979) allow processing of larger volumes of blood, our cell separator 
has the advantage that the buffy coats are isolated in much smaller volumes (5 -6  ml) 
and that the time required to prepare and carry out a separation is relatively short. 
Furthermore, compared to the techniques mentioned above, better cell separation 
was obtained, and recovery of mononuclear cells was much higher while contamina­
tion with granulocytes and red blood cells was similar or less. It may also be 
mentioned that buffy coats formed in the cell separator may be kept sterile since all 
parts of the device, and the Maxidens, are autoclavable.
This device extends the range of techniques available to separate large as well as 
small volumes of blood, since it allows efficient separation of platelets and mono­
nuclear cells under sterile conditions. Further research is necessary to optimize the 
technique in such a way that it can be used routinely for isolation of different blood 
components,
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